Glycopyrrolate 0.2mg | 1mL Injectable SDV

Product Overview: 

Solco Healthcare Glycopyrrolate 0.2mg | 1mL Injectable Single-Dose Vial (SDV) is a sterile, non-pyrogenic solution formulated for intramuscular (IM) or intravenous (IV) administration. Glycopyrrolate is an anticholinergic agent used in various clinical settings to reduce secretions, manage vagal reflexes during anesthesia, and as a preoperative adjunct to anesthetics.

Key Features:

• Concentration and Dosage: Contains Glycopyrrolate 0.2mg per mL in a 1mL single-dose vial, designed for precise and controlled dosing.
• Clinical Applications: Primarily utilized to reduce salivary, pharyngeal, tracheal, and bronchial secretions; also used to counteract drug-induced bradycardia and reduce reflex parasympathetic effects during surgery.
• Pharmacological Action: Functions by inhibiting the action of acetylcholine on muscarinic receptors, reducing the activity of the parasympathetic nervous system.
• Sterile and Ready-to-Use: Provided in a single-dose vial to ensure sterility and minimize contamination risk, ideal for use in hospital, surgical, and emergency settings.

Intended Use: 

Glycopyrrolate Injectable is indicated for use as a preoperative medication to reduce secretions in the mouth, throat, airway, and stomach, and to maintain heart rate stability during surgical procedures. It is also used as an adjunct in the treatment of peptic ulcers by reducing stomach acid production.

Benefits:

• Effective Secretion Control: Helps manage excessive secretions, which is crucial in maintaining clear airways during surgery or critical care.
• Improved Cardiovascular Stability: Provides reliable control over heart rate, especially in situations involving vagal-induced bradycardia.
• Convenience and Safety: Packaged in a single-dose vial for easy administration and to reduce waste, ensuring safety and sterility.